SOURCE: OR-Live, Inc.

February 26, 2008 07:15 ET

REMINDER: ORLive Presents: Reality EP: Epicardial Ablation for Atrial Fibrillation -- Minimally Invasive Pulmonary Vein Isolation and Partial Autonomic Denervation Procedure

Live Webcast February 26, 2008 5:00 PM CST (23:00 UTC) From THE HEART HOSPITAL Baylor Plano, Plano, TX

PLANO, TX--(Marketwire - February 26, 2008) - The Heart Rhythm Society's second live webcast of the Reality EP series titled Epicardial Ablation for Atrial Fibrillation will take place on Tuesday, February 26 at 5 PM CST on www.OR-Live.com.

Reality EP is a series of quarterly, live webcasts featuring state-of-the-art procedures in clinical cardiac electrophysiology with commentary by the world's leading EP medical professionals. The Epicardial Ablation for Atrial Fibrillation live webcast will feature a panel discussion of a minimally invasive pulmonary vein isolation and partial autonomic denervation procedure for the surgical ablation of atrial fibrillation (AF) performed at THE HEART HOSPITAL Baylor Plano.

Douglas Packer, MD, FHRS, a leading electrophysiologist with the Heart Rhythm Society, will co-moderate the panel with James Edgerton, MD, who specializes in surgical ablations, and Hafiza Khan, MD, the referring electrophysiologist. The experts will discuss the evolution of the minimally invasive surgical approach to atrial fibrillation, the means by which electrophysiologists and cardiothoracic surgeons can work together, and will cover the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.

You can download the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation beneath the Webcast Links section to the right on the Webcast launch page.

The patient is a 54 year-old male who in 1996 was diagnosed with paroxysmal atrial fibrillation (AF). The patient was treated with Quinidine and Digoxin from 1996 to 2000. The patient then began experiencing frequent episodes of atrial fibrillation and was switched to Flecainide and Warfarin in 2001. In mid-2002, the patient experienced further progression of symptomatic episodes of AF lasting up to three days, during which the patient suffered from low energy levels, fatigue, and dyspnea. The patient then progressed to persistent AF in 2003. Over the last four years, the patient has experienced palpitations, fatigue during high levels of exertion, and occasionally dyspnea both at rest and during physician exertion.The patient's echocardiogram showed no valvular incompetence, good ventricular function, and an enlarged left atrium at 4.5cm.

The Epicardial Ablation for Atrial Fibrillation live webcast is supported by an educational grant from AtriCure and is part of the Society's AF 360 degrees Initiative, a comprehensive and coordinated effort to change treatment behaviors among clinicians, influence regulators and legislators toward supporting optimum care protocols, and engage patients and caregivers in AF self-management.

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of over 4,400 heart rhythm professionals in more than 67 countries around the world. www.HRSonline.org

Contact Information